تازاروتين

• Tazorac(R) topical cream 0.1%:

For the topical treatment of patients with acne vulgaris: Cleanse the face gently. After the skin is dry, apply a thin layer (2 mg/cm2) once a day, in the evening, to the skin areas where acne lesions appear. Use enough to cover the entire affected area.

• Topical foam 0.1%:

For the topical treatment of acne vulgaris: After washing with a mild cleanser and fully drying the affected area, tazarotene topical foam should be applied once a day in the evening. Dispense a small amount of foam into the palm of the hand. Using fingertips, apply only enough foam to lightly cover the entire affected areas of the face and/or upper trunk with a thin layer; gently massage the foam into the skin until the foam disappears.

• Topical gel 0.1%:

For the topical treatment of patients with facial acne vulgaris of mild to moderate severity: Cleanse the face gently. After the skin is dry, apply a thin film (2 mg/cm2) once a day, in the evening, to the skin where acne lesions appear. Use enough to cover the entire affected area.

• Tazorac(R) topical cream 0.05% and 0.1%:

For the topical treatment of patients with plaque psoriasis: Apply once a day, in the evening, to psoriatic lesions, using enough (2 mg/cm2) to cover only the lesion with a thin film. If a bath or shower is taken prior to application, the skin should be dry before applying the cream. Because unaffected skin may be more susceptible to irritation, application of tazarotene topical cream to these areas should be carefully avoided.

• Topical gel 0.05% and 0.1%:

For the topical treatment of patients with stable plaque psoriasis of up to 20% body surface area involvement: Apply once a day, in the evening, to psoriatic lesions, using enough (2 mg/cm2) to cover only the lesion with a thin film to no more than 20% of body surface area. If a bath or shower is taken prior to application, the skin should be dry before applying the gel. Because unaffected skin may be more susceptible to irritation, application of tazarotene topical gel to these areas should be carefully avoided.

Treatment should start with tazarotene topical cream or gel 0.05%, with strength increased to 0.1% if tolerated and medically indicated.

• Tazorac(R) topical cream 0.1%:

For the topical treatment of patients with acne vulgaris: Cleanse the face gently. After the skin is dry, apply a thin layer (2 mg/cm2) once a day, in the evening, to the skin areas where acne lesions appear. Use enough to cover the entire affected area.

• Topical foam 0.1%:

For the topical treatment of acne vulgaris: After washing with a mild cleanser and fully drying the affected area, tazarotene topical foam should be applied once a day in the evening. Dispense a small amount of foam into the palm of the hand. Using fingertips, apply only enough foam to lightly cover the entire affected areas of the face and/or upper trunk with a thin layer; gently massage the foam into the skin until the foam disappears.

• Topical gel 0.1%:

For the topical treatment of patients with facial acne vulgaris of mild to moderate severity: Cleanse the face gently. After the skin is dry, apply a thin film (2 mg/cm2) once a day, in the evening, to the skin where acne lesions appear. Use enough to cover the entire affected area. What other drugs will affect tazarotene topical?